High Court Ruling Won't End 'Conversion Therapy' Battles
The U.S. Supreme Court's rejection of Colorado's ban on what is commonly known as gay conversion therapy may have rendered dozens of similar laws toothless, but don't expect it to be the end of legal challenges in this arena.
5 Firms Advise On Gilead's Up To $5B Tubulis Acquisition
Gilead Sciences Inc. said Tuesday it has agreed to acquire German clinical-stage cancer biotechnology company Tubulis for up to $5 billion, in a deal steered by five law firms.
As FCA Meets 340B, Geyser Of Qui Tam Suits May Erupt
A Ninth Circuit ruling on the intersection of two of the most contentious laws in healthcare may be a combustible mix that triggers a new wave of fraud litigation.
High Court Ruling Won't End 'Conversion Therapy' Battles
The U.S. Supreme Court's rejection of Colorado's ban on what is commonly known as gay conversion therapy may have rendered dozens of similar laws toothless, but don't expect it to be the end of legal challenges in this arena.
5 Firms Advise On Gilead's Up To $5B Tubulis Acquisition
Gilead Sciences Inc. said Tuesday it has agreed to acquire German clinical-stage cancer biotechnology company Tubulis for up to $5 billion, in a deal steered by five law firms.
As FCA Meets 340B, Geyser Of Qui Tam Suits May Erupt
A Ninth Circuit ruling on the intersection of two of the most contentious laws in healthcare may be a combustible mix that triggers a new wave of fraud litigation.
Expert Analysis
New draft guidance from the U.S. Food and Drug Administration provides formal insight on how drug manufacturers ar... (more story)
Amarin v. Hikma, which is set for oral argument in the U.S. Supreme Court this month, highlights the distinction b... (more story)
An aging population and evolving state regulations underscore a critical reality that senior housing assets can un... (more story)
Deals & Corporate Governance More
A smattering of billion-dollar M&A transactions could be the kickoff of an exciting period for dealmaking.
The federal government's scrutiny of long-recognized concerns about the Medicare Advantage industry is heating up. Experts are watching to see what long-term changes come of it.
A documentary filmmaker who worked for ImmunityBio Inc. will pay the U.S. Securities and Exchange Commission over $332,000 to end claims she scrambled to sell off her stake in the biotechnology company as it p... (more story)
Law360 is pleased to announce the formation of its 2026 Editorial Advisory Boards.
A Nebraska testing laboratory failed to prove that Aetna underpaid more than $53 million for COVID-19 testing services, a California federal judge has ruled, dismissing the lab's federal racketeering and state... (more story)
Federal Trade Commission staff has warned Tennessee legislators about the potential harm to patients if they pass a proposal to end the state's oversight of Ballad Health while the hospital system still has a monopoly.
Digital Health & Technology More
An Inova Health Care Services patient is urging a Virginia federal judge to grant final approval to a $3.1 million deal to resolve claims the healthcare system unlawfully shared private health information with... (more story)
Less than a month ahead of trial, a New York fertility clinic has agreed to resolve a suit accusing it of negligently allowing a woman's eggs to be destroyed due to alleged mishandling, according to documents ... (more story)
Two attorneys looking to temporarily helm a series of putative data breach class actions targeting a radiology firm have failed to become interim co-lead class counsel, as a North Carolina Business Court judge... (more story)
Michigan's attorney general is urging a federal court to reject a renewed bid by pharmacy benefit managers to pause discovery in an antitrust case accusing them of price-fixing reimbursement rates, claiming th... (more story)
BakerHostetler announced Tuesday it has welcomed data privacy litigator Spencer Persson from Davis Wright Tremaine to its digital assets and data management practice group as partner, bringing in years of expe... (more story)
An Oregon federal judge has refused to throw out a putative class action accusing a fertility clinic of deploying tracking technology that illegally transmitted its website visitors' protected health informati... (more story)
Policy & Compliance More
EmblemHealth asked a Massachusetts federal judge to let it seek First Circuit intervention against a decision that cut in half its proposed class action accusing AstraZeneca unit Alexion of using sham patents ... (more story)
Pest control company Rentokil can't escape a proposed class action alleging it unlawfully charged tobacco users more for health benefits without providing a reasonable way to avoid the fee, with a Pennsylvania... (more story)
A Pennsylvania federal judge on Thursday called the addition of overdose prevention nonprofit Safehouse's president as a counterclaim plaintiff in the government's suit to stop it from launching a safe-injecti... (more story)
The administration of President Donald Trump again urged the Supreme Court not to hear a challenge to the Medicare drug price negotiation program, arguing against a constitutional challenge brought by Boehring... (more story)
The U.S. Department of Education denied accusations by 16 U.S. states that it is flouting a court order to restore nearly $1 billion in K–12 mental health grants, arguing in a Western District of Washington fi... (more story)
Federally funded healthcare providers in the 340B Drug Pricing Program are using an "overly broad" interpretation of the word "patient" based on government guidelines, and it's leading to them abusing 340B dis... (more story)